Search Results - "Schlotter, C."

Refine Results
  1. 1

    Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease by Helms, M W, Kemming, D, Pospisil, H, Vogt, U, Buerger, H, Korsching, E, Liedtke, C, Schlotter, C M, Wang, A, Chan, S Y, Brandt, B H

    Published in British journal of cancer (02-09-2008)
    “…Gains of chromosomes 7p and 8q are associated with poor prognosis among oestrogen receptor-positive (ER+) stage I/II breast cancer. To identify transcriptional…”
    Get full text
    Journal Article
  2. 2

    Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: Double-differential polymerase chain reaction (ddPCR) for clinical diagnosis by Brandt, B., Vogt, U., Schlotter, C.M., Jackisch, C., Werkmeister, R., Thomas, M., von Eiff, M., Bosse, U., Assmann, G., Zänker, K.S.

    Published in Gene (14-06-1995)
    “…We have determined the average gene copy numbers (AGCN) of the erbB-1 gene, encoding the epidermal growth factor receptor (EGF-R), the erbB-2 and the erbB-3…”
    Get full text
    Journal Article
  3. 3

    Whole genome expression analysis for biologic rational pathway modeling: application in cancer prognosis and therapy prediction by Kemming, D, Vogt, U, Tidow, N, Schlotter, C M, Bürger, H, Helms, M W, Korsching, E, Granetzny, A, Boseila, A, Hillejan, L, Marra, A, Ergönenc, Y, Adigüzel, H, Brandt, B

    Published in Molecular diagnosis & therapy (01-01-2006)
    “…Using semi-quantitative microarray technology, almost every one of the approximately 30 000 human genes can be analyzed simultaneously with a low rate of…”
    Get full text
    Journal Article
  4. 4

    Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer by Vogt, Ulf, Bielawski, Krzysztof, Schlotter, Claus M, Bosse, Ulrich, Falkiewicz, Bogdan, Podhajska, Anna J

    Published in Gene (26-11-1998)
    “…ErbB-4 protein is a recently discovered member of the ErbB family. The role of ErbB-4 protein in mammary-gland tissue has not been definitively established. To…”
    Get full text
    Journal Article
  5. 5

    Relationship of c-myc and erbB oncogene family gene aberrations and other selected factors to ex vivo chemosensitivity of ovarian cancer in the modified ATP-chemosensitivity assay by Vogt, U, Falkiewicz, B, Bielawski, K, Bosse, U, Schlotter, C M

    Published in Acta biochimica polonica (01-01-2000)
    “…A pilot study on relationships of selected molecular factors [erbB-1, erbB-2, erbB-3, and c-myc oncogene average gene copy numbers (AGCN); steroid receptors…”
    Get full text
    Journal Article
  6. 6

    c-myc oncogene gene dosage, serum CEA and CA-15.3 antigen levels, and cellular DNA values in relation to ex vivo chemosensitivity of primary human breast cancer by Falkiewicz, B, Schlotter, C M, Bosse, U, Bielawski, K, Vogt, U

    Published in Acta biochimica polonica (01-01-2000)
    “…A pilot study on relationships of selected molecular factors (c-myc oncogene average gene copy numbers (AGCN); serum CEA and CA 15.3 antigen levels; tumor…”
    Get full text
    Journal Article
  7. 7

    Gene Expression Profiling for Therapy Prediction in a Breast Cancer Neoadjuvant Therapy Study Applying Docetaxel/Epirubicin/Cyclophosphamide by Kemming, D., Schlotter, C., Bosse, U., Vogt, U., Muhs, H., von der Assen, A., Brandt, B.

    Published in Cancer research (Chicago, Ill.) (15-12-2009)
    “…Background: Gene expression profiling is a powerful tool to identify markers associated with clinical and therapy outcome of cancer patients. Prediction of the…”
    Get full text
    Journal Article
  8. 8

    Prediction of Metastasis in Node-Negative, Hormone Receptor Positive, Tamoxifen Adjuvant Treated Primary Breast Cancer Patients Using Ki-67 (IHC) and RT-PCR Based 14-Gene Prognostic Signature by Schlotter, C., Wassmann, K., Bosse, U., Kemming, D., Brandt, B., Vogt, U.

    Published in Cancer research (Chicago, Ill.) (15-12-2009)
    “…Background: Risk estimation based on the recommendations of St. Gallen Consensus commonly decides for additional cytostatic therapy in node-negative (N-),…”
    Get full text
    Journal Article
  9. 9

    Human papillomavirus genotypes in cervical cancer with different histological features by Jakob, C, Schlotter, C M, Bosse, U, Füzesi, L

    Published in Gynecologic and obstetric investigation (01-01-2000)
    “…We report the case of a 32-year-old woman having developed two cervical cancers synchronously, an adenocarcinoma and a squamous cell carcinoma. Polymerase…”
    Get more information
    Journal Article
  10. 10

    Semi-quantitative gene expression profiling for therapy prediction in a breast cancer neoadjuvant therapy study applying docetaxel/epirubicin/cyclophosphamide by Vogt, U., Kemming, D., Brandt, B., Bosse, U., Bonk, U., Assen, A. v. d., Muhs, H. J., Schlotter, C. M.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 21144 Background: More than 28000 curated human genes can be analyzed semi-quantitatively using a chemiluminescent detection technology and 60mer…”
    Get full text
    Journal Article
  11. 11

    Therapy prediction in a breast cancer primary systemic chemotherapy (PST) study applying docetaxel/epirubicin/cyclophosphamide (TEC) by gene expression profiling by Vogt, U., Brandt, B., Bosse, U., Bonk, U., Adigüzel, H., Ergoenenc, Y., Kemming, D., Schlotter, C.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 10049 Background: Currently there are no tests to assist in selecting the optimal PST regimen for breast cancer patients. Primary study goals of…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Evaluation of infants with acidosis using a perinatal "negative factor" score by Schlotter, C M, Michaelis, R, Otto, S, Dopfer, R

    Published in Archives of Gynecology (01-03-1982)
    “…Using Prechtl's concept of optimal conditions as modified by Michaelis et al. [7] we analysed the case records of 50 acidotic newborn infants (umbilical artery…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Impact of DNA image cytometry (ICM) parameter and established prognostic factors on disease free survival (DFS) and overall survival (OS) of node-negative breast cancer (NNBC) patients by Schlotter, C M, Vogt, U, Bosse, U, Wassmann, K

    Published in Zentralblatt für Gynäkologie (01-09-2003)
    “…DNA ICM allows measurement of nuclear DNA content and genotypical grading of malignancy. The aim of this study was to prove the prognostic value of DNA…”
    Get more information
    Journal Article
  18. 18

    Pre-pathologic-pathologic cardiotocographic pattern in second stage of labor. Analysis of the incidence of acidosis and recommendations for fetal blood gas analysis by Schlotter, C M

    Published in Zentralblatt für Gynäkologie (1997)
    “…Fetal heart rate (FHR) patterns from 746 consecutive, documented vaginal deliveries within a 1 year period were reported on using the Hammacher Score…”
    Get more information
    Journal Article
  19. 19
  20. 20

    C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer by Schlotter, Claus M, Vogt, Ulf, Bosse, Ulrich, Mersch, Berthold, Wassmann, Katja

    Published in Breast cancer research : BCR (01-01-2003)
    “…At present, node-negative, high-risk breast cancer patients cannot be identified with sufficient accuracy. Consequently, further strong prognostic factors are…”
    Get full text
    Journal Article